Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response. Read more about Pharma[e]cology: How the Gut Microbiome Contributes to Variations in Drug Response.
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance. Read more about Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance.
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure. Read more about Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Read more about Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases.
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Read more about Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation. Read more about Regulation and inhibition of arachidonic acid omega-hydroxylases and 20-HETE formation.
The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Read more about The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions.
A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors. Read more about A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors.
Role of organic cation transporters in drug absorption and elimination. Read more about Role of organic cation transporters in drug absorption and elimination.
